Extensions for Using Data Elements from FHIR DSTU2 in FHIR R5
0.1.0 - STU
Extensions for Using Data Elements from FHIR DSTU2 in FHIR R5
0.1.0 - STU
Extensions for Using Data Elements from FHIR DSTU2 in FHIR R5 - Downloaded Version null See the Directory of published versions
| Page standards status: Trial-use | Maturity Level: 0 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="R2-v3-substanceAdminSubstitution-for-R5"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet R2-v3-substanceAdminSubstitution-for-R5</b></p><a name="R2-v3-substanceAdminSubstitution-for-R5"> </a><a name="hcR2-v3-substanceAdminSubstitution-for-R5"> </a><p>This value set expansion contains 10 concepts.</p><table class="codes"><tr><td><b>System</b></td><td><b>Version</b></td><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-BC"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-BC">BC</a></td><td>brand composition</td><td>Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-E"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-E">E</a></td><td>equivalent</td><td>Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-EC"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-EC">EC</a></td><td>equivalent composition</td><td>Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-F"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-F">F</a></td><td>formulary</td><td>Description: This substitution was performed or is permitted based on formulary guidelines.</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-G"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-G">G</a></td><td>generic composition</td><td>Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-N"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-N">N</a></td><td>none</td><td>No substitution occurred or is permitted.</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-TB"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-TB">TB</a></td><td>therapeutic brand</td><td>Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > Examples: Zantac for Tagamet</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-TE"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-TE">TE</a></td><td>therapeutic alternative</td><td>Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-TG"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-TG">TG</a></td><td>therapeutic generic</td><td>Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > Examples: Ranitidine for cimetidine</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-_ActSubstanceAdminSubstitutionCode"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-_ActSubstanceAdminSubstitutionCode">_ActSubstanceAdminSubstitutionCode</a></td><td>ActSubstanceAdminSubstitutionCode</td><td>Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.</td></tr></table></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="fhir"/>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/package-source">
<extension url="packageId">
<valueId value="hl7.fhir.uv.xver-r2.r5"/>
</extension>
<extension url="version">
<valueString value="0.1.0"/>
</extension>
<extension url="uri">
<valueUri
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r5"/>
</extension>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
<valueInteger value="0">
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
<valueCanonical
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r5"/>
</extension>
</valueInteger>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
<valueCode value="trial-use">
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
<valueCanonical
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r5"/>
</extension>
</valueCode>
</extension>
<url
value="http://hl7.org/fhir/uv/xver/ValueSet/R2-v3-substanceAdminSubstitution-for-R5"/>
<version value="0.1.0"/>
<name value="R2V3SubstanceAdminSubstitutionForR5"/>
<title
value="Cross-version ValueSet DSTU2.v3 Code System substanceAdminSubstitution for use in FHIR R5"/>
<status value="active"/>
<experimental value="false"/>
<date value="2026-03-17T21:02:03.8104715+00:00"/>
<publisher value="FHIR Infrastructure"/>
<contact>
<name value="FHIR Infrastructure"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/fiwg"/>
</telecom>
</contact>
<description
value="This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31` for use in FHIR R5."/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<purpose
value="This value set is part of the cross-version definitions generated to enable use of the
value set `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31` as defined in FHIR DSTU2
in FHIR R5.
The source value set is bound to the following FHIR DSTU2 elements:
*
Note that all concepts are included in this cross-version definition because no concepts have compatible representations
Following are the generation technical comments:
FHIR ValueSet `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31`, defined in FHIR DSTU2 does not have any mapping to FHIR R5"/>
<compose>
<include>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<concept>
<code value="BC"/>
<display value="brand composition"/>
</concept>
<concept>
<code value="E"/>
<display value="equivalent"/>
</concept>
<concept>
<code value="EC"/>
<display value="equivalent composition"/>
</concept>
<concept>
<code value="F"/>
<display value="formulary"/>
</concept>
<concept>
<code value="G"/>
<display value="generic composition"/>
</concept>
<concept>
<code value="N"/>
<display value="none"/>
</concept>
<concept>
<code value="TB"/>
<display value="therapeutic brand"/>
</concept>
<concept>
<code value="TE"/>
<display value="therapeutic alternative"/>
</concept>
<concept>
<code value="TG"/>
<display value="therapeutic generic"/>
</concept>
<concept>
<code value="_ActSubstanceAdminSubstitutionCode"/>
<display value="ActSubstanceAdminSubstitutionCode"/>
</concept>
</include>
</compose>
<expansion>
<timestamp value="2026-03-17T21:02:03.8104715+00:00"/>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="BC"/>
<display value="brand composition"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="E"/>
<display value="equivalent"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="EC"/>
<display value="equivalent composition"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="F"/>
<display value="formulary"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="G"/>
<display value="generic composition"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="N"/>
<display value="none"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="TB"/>
<display value="therapeutic brand"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="TE"/>
<display value="therapeutic alternative"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="TG"/>
<display value="therapeutic generic"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="_ActSubstanceAdminSubstitutionCode"/>
<display value="ActSubstanceAdminSubstitutionCode"/>
</contains>
</expansion>
</ValueSet>
IG © 2025+ FHIR Infrastructure. Package hl7.fhir.uv.xver-r2.r5#0.1.0 based on FHIR 5.0.0. Generated 2026-03-20
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change